DaVita Inc. (NYSE:DVA) Shares Sold by Geode Capital Management LLC

Geode Capital Management LLC decreased its holdings in shares of DaVita Inc. (NYSE:DVA - Free Report) by 7.5% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,164,176 shares of the company's stock after selling 94,269 shares during the period. Geode Capital Management LLC owned about 1.42% of DaVita worth $190,193,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also recently made changes to their positions in the stock. Transcendent Capital Group LLC purchased a new stake in DaVita during the 3rd quarter valued at approximately $25,000. Blue Trust Inc. increased its position in DaVita by 58.6% in the second quarter. Blue Trust Inc. now owns 211 shares of the company's stock worth $29,000 after purchasing an additional 78 shares during the last quarter. Family Firm Inc. bought a new position in DaVita during the second quarter valued at $43,000. Quarry LP bought a new stake in shares of DaVita in the 3rd quarter worth about $60,000. Finally, Point72 Hong Kong Ltd bought a new position in shares of DaVita in the 2nd quarter valued at about $68,000. Institutional investors own 90.12% of the company's stock.

DaVita Trading Down 1.4 %

Shares of NYSE:DVA traded down $2.14 during trading on Monday, reaching $150.59. 783,224 shares of the company were exchanged, compared to its average volume of 809,323. The company has a debt-to-equity ratio of 15.78, a current ratio of 1.37 and a quick ratio of 1.33. The firm has a market capitalization of $12.35 billion, a PE ratio of 16.48, a P/E/G ratio of 0.86 and a beta of 0.90. The business's fifty day simple moving average is $157.94 and its 200-day simple moving average is $150.86. DaVita Inc. has a 12-month low of $103.40 and a 12-month high of $169.51.

DaVita (NYSE:DVA - Get Free Report) last released its quarterly earnings results on Tuesday, October 29th. The company reported $2.59 EPS for the quarter, missing the consensus estimate of $2.76 by ($0.17). The company had revenue of $3.26 billion during the quarter, compared to the consensus estimate of $3.25 billion. DaVita had a return on equity of 88.18% and a net margin of 6.53%. The company's revenue was up 4.6% on a year-over-year basis. During the same period in the previous year, the firm posted $2.85 earnings per share. On average, research analysts anticipate that DaVita Inc. will post 9.71 EPS for the current year.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on the company. Truist Financial raised their price objective on DaVita from $165.00 to $175.00 and gave the company a "hold" rating in a research note on Monday, October 7th. Barclays boosted their price objective on shares of DaVita from $150.00 to $164.00 and gave the company an "equal weight" rating in a research report on Thursday, October 31st. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of "Hold" and a consensus price target of $161.80.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.